Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. P.G.M. (Peter) Mol

Publicaties

Biomarkers for neurodegenerative diseases in regulatory decision-making by the European Medicines Agency

Dispensing Patterns of Inhaled Asthma Medication Before and During COVID-19 Among Young Adults in the Netherlands: A Retrospective Inception Cohort Study

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: A systematic review and meta-analysis of European studies published up to 22 January 2024

Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients

Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review

Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing

Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials

Stakeholders' Perspectives Toward the Use of Patient Registry Data for Decision-Making on Medicines: A Cross-Sectional Survey

Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions

Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop

Pers/media

CBG Collegedag 2024: uitdagingen veranderen in kansen

Towards a more efficient use of registry-based real-world data in Europe: the More-EUROPA project

Peter Mol en Patrick Vrijlandt namens Nederland in het Europese CHMP

Oratie Peter Mol over kennisuitwisseling tussen wetenschap en medicijnautoriteit